Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinomaLEEF, George; THOMAS, Sufi Mary.Oral oncology (1997). 2013, Vol 49, Num 5, pp 381-386, issn 1368-8375, 6 p.Article

The Current State of Head and Neck Cancer Gene TherapyTHOMAS, Sufi Mary; RUBIN GRANDIS, Jennifer.Human gene therapy. 2009, Vol 20, Num 12, pp 1565-1575, issn 1043-0342, 11 p.Article

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerARGIRIS, Athanassios; LEE, Steve C; FEINSTEIN, Trevor et al.Oral oncology (1997). 2011, Vol 47, Num 10, pp 961-966, issn 1368-8375, 6 p.Article

Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFRJUN WANG; XIN ZHANG; THOMAS, Sufi M et al.Oncogene (Basingstoke). 2005, Vol 24, Num 38, pp 5897-5904, issn 0950-9232, 8 p.Article

Synthesis of Conformationally Preorganized and Cell-Permeable Guanidine-Based γ-Peptide Nucleic Acids (yGPNAs)SAHU, Bichismita; CHENNA, Venugopal; LATHROP, Kira L et al.Journal of organic chemistry. 2009, Vol 74, Num 4, pp 1509-1516, issn 0022-3263, 8 p.Article

Epidermal growth factor receptor-stimulated activation of phospholipase Cγ-1 promotes invasion of head and neck squamous cell carcinomaTHOMAS, Sufi Mary; COPPELLI, Francesca M; WELLS, Alan et al.Cancer research (Baltimore). 2003, Vol 63, Num 17, pp 5629-5635, issn 0008-5472, 7 p.Article

Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to CetuximabBHOLA, Neil E; THOMAS, Sufi M; FREILINO, Maria et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 4996-5004, issn 1078-0432, 9 p.Article

Carfilzomib and ONX 0912 Inhibit Cell Survival and Tumor Growth of Head and Neck Cancer and Their Activities Are Enhanced by Suppression of Mcl-1 or AutophagyYAN ZANG; THOMAS, Sufi M; CHAN, Elena T et al.Clinical cancer research (Print). 2012, Vol 18, Num 20, pp 5639-5649, issn 1078-0432, 11 p.Article

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: A pilot randomized trial in head and neck cancerMOSKOWITZ, Howard S; GOODING, William E; THOMAS, Sufi M et al.Oral oncology (1997). 2012, Vol 48, Num 11, pp 1136-1145, issn 1368-8375, 10 p.Article

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to Pseudomonas exotoxin transforming growth factor α-PE38THOMAS, Sufi M; QING ZENG; EPPERLY, Michael W et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 7079-7087, issn 1078-0432, 9 p.Article

Src family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cellsQING ZHANG; THOMAS, Sufi M; SICHUAN XI et al.Cancer research (Baltimore). 2004, Vol 64, Num 17, pp 6166-6173, issn 0008-5472, 8 p.Article

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor InhibitorsLEEMAN-NEILL, Rebecca J; QUAN CAI; JOYCE, Sonali C et al.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2571-2579, issn 1078-0432, 9 p.Article

Combined Inhibition of c-Src and Epidermal Growth Factor Receptor Abrogates Growth and Invasion of Head and Neck Squamous Cell CarcinomaKOPPIKAR, Priya; CHOI, Seung-Ho; GRANDIS, Jennifer R et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4284-4291, issn 1078-0432, 8 p.Article

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinomaTHOMAS, Sufi Mary; BHOLA, Neil E; QING ZHANG et al.Cancer research (Baltimore). 2006, Vol 66, Num 24, pp 11831-11839, issn 0008-5472, 9 p.Article

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in CancerSEN, Malabika; JOYCE, Sonali; PANAHANDEH, Mary et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4986-4996, issn 1078-0432, 11 p.Article

Combined Inhibition of PLCγ-1 and c-Src Abrogates Epidermal Growth Factor Receptor-Mediated Head and Neck Squamous Cell Carcinoma InvasionNOZAWA, Hiroshi; HOWELL, Gina; SUZUKI, Shinsuke et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4336-4344, issn 1078-0432, 9 p.Article

Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptorWAI YAN LUI, Vivian; THOMAS, Sufi Mary; QING ZHANG et al.Oncogene (Basingstoke). 2003, Vol 22, Num 40, pp 6183-6193, issn 0950-9232, 11 p.Article

HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell CancerKNOWLES, Lynn M; STABILE, Laura P; MORGAN, Sarah et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3740-3750, issn 1078-0432, 11 p.Article

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targetingSOK, John C; COPPELLI, Francesca M; GOODING, William E et al.Clinical cancer research. 2006, Vol 12, Num 17, pp 5064-5073, issn 1078-0432, 10 p.Article

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerFRIDMAN, Jordan S; CAULDER, Eian; GRANDIS, Jennifer R et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1892-1902, issn 1078-0432, 11 p.Article

Erlotinib, Erlotinib-Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck CancerGROSS, Neil D; BAUMAN, Julie E; CONRADS, Thomas P et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3289-3298, issn 1078-0432, 10 p.Article

Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer : First Human Application and Potential Antitumor MechanismsLAI, Stephen Y; KOPPIKAR, Priya; LUI, Vivian W. Y et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1235-1242, issn 0732-183X, 8 p.Article

Lack of toxicity of a STAT3 decoy oligonucleotideSEN, Malabika; TOSCA, Patricia J; CHANGYOU LI et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 6, pp 983-995, issn 0344-5704, 13 p.Article

Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical StudiesSHIN, Dong M; HONGZHENG ZHANG; BRANDES, Johann C et al.Clinical cancer research (Print). 2013, Vol 19, Num 5, pp 1244-1256, issn 1078-0432, 13 p.Article